Aldo-Keto Reductase 1C3 Mediates Chemotherapy Resistance in Esophageal Adenocarcinoma via ROS Detoxification

SIMPLE SUMMARY: The multidrug resistance of EAC is one of the major obstacles to chemotherapeutic efficiency. Our study aims to explore the molecular mechanism of AKR1C3 as a novel therapeutic target to overcome chemotherapy resistance for EAC patients. We demonstrate that AKR1C3 renders chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chenghui, Wang, Zhefang, Li, Jiahui, Wu, Xiaolin, Fan, Ningbo, Li, Dai, Liu, Fanyu, Plum, Patrick S., Hoppe, Sascha, Hillmer, Axel M., Quaas, Alexandar, Gebauer, Florian, Chon, Seung-Hun, Bruns, Christiane J., Zhao, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156851/
https://www.ncbi.nlm.nih.gov/pubmed/34065695
http://dx.doi.org/10.3390/cancers13102403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156851/
https://www.ncbi.nlm.nih.gov/pubmed/34065695
http://dx.doi.org/10.3390/cancers13102403

Ejemplares similares